Joseph W. Harding - Publications

Affiliations: 
Washington State University, Pullman, WA, United States 
Area:
hippocampus, dementia

168 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Vanderwerff BR, Church KJ, Kawas LH, Harding JW. Comparative characterization of the HGF/Met and MSP/Ron systems in primary pancreatic adenocarcinoma. Cytokine. 123: 154762. PMID 31254927 DOI: 10.1016/j.cyto.2019.154762  0.48
2019 Wright JW, Church KJ, Harding JW. Hepatocyte Growth Factor and Macrophage-Stimulating Protein "Hinge" Analogs to Treat Pancreatic Cancer. Current Cancer Drug Targets. PMID 30914029 DOI: 10.2174/1568009619666190326130008  0.48
2019 Wright JW, Harding JW. Contributions by the Brain Renin-Angiotensin System to Memory, Cognition, and Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 30664507 DOI: 10.3233/JAD-181035  0.4
2018 Church KJ, Vanderwerff BR, Riggers RR, Mateo-Victoriano B, Fagnan M, Harris PH, LeValley JC, Harding JW. Norleual, a hepatocyte growth factor and macrophage stimulating protein dual antagonist, increases pancreatic cancer sensitivity to gemcitabine. Anti-Cancer Drugs. PMID 29389804 DOI: 10.1097/CAD.0000000000000598  0.48
2016 Church KJ, Vanderwerff BR, Riggers RR, McMicheal MD, Mateo-Victoriano B, Sukumar SR, Harding JW. Analogs of the hepatocyte growth factor and macrophage-stimulating protein hinge regions act as Met and Ron dual inhibitors in pancreatic cancer cells. Anti-Cancer Drugs. PMID 27314431 DOI: 10.1097/CAD.0000000000000390  0.48
2015 Uribe PM, Kawas LH, Harding JW, Coffin AB. Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposure. Frontiers in Cellular Neuroscience. 9: 3. PMID 25674052 DOI: 10.3389/fncel.2015.00003  0.48
2015 Wright JW, Harding JW. The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. 45: 985-1000. PMID 25649658 DOI: 10.3233/JAD-142814  0.68
2015 Wright JW, Kawas LH, Harding JW. The development of small molecule angiotensin IV analogs to treat Alzheimer's and Parkinson's diseases. Progress in Neurobiology. 125: 26-46. PMID 25455861 DOI: 10.1016/j.pneurobio.2014.11.004  0.68
2014 Benoist CC, Kawas LH, Zhu M, Tyson KA, Stillmaker L, Appleyard SM, Wright JW, Wayman GA, Harding JW. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met system. The Journal of Pharmacology and Experimental Therapeutics. 351: 390-402. PMID 25187433 DOI: 10.1124/jpet.114.218735  0.68
2013 Natarajan R, Harding JW, Wright JW. A role for matrix metalloproteinases in nicotine-induced conditioned place preference and relapse in adolescent female rats. Journal of Experimental Neuroscience. 7: 1-14. PMID 25157203 DOI: 10.4137/JEN.S11381  0.68
2013 Wright JW, Kawas LH, Harding JW. A Role for the Brain RAS in Alzheimer's and Parkinson's Diseases. Frontiers in Endocrinology. 4: 158. PMID 24298267 DOI: 10.3389/fendo.2013.00158  0.48
2013 McCoy AT, Benoist CC, Wright JW, Kawas LH, Bule-Ghogare JM, Zhu M, Appleyard SM, Wayman GA, Harding JW. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agents. The Journal of Pharmacology and Experimental Therapeutics. 344: 141-54. PMID 23055539 DOI: 10.1124/jpet.112.199497  0.68
2013 Kawas LH, Benoist CC, Harding JW, Wayman GA, Abu-Lail NI. Nanoscale mapping of the Met receptor on hippocampal neurons by AFM and confocal microscopy. Nanomedicine : Nanotechnology, Biology, and Medicine. 9: 428-38. PMID 22960190 DOI: 10.1016/j.nano.2012.08.008  0.68
2013 Wright JW, Harding JW. The brain renin-angiotensin system: a diversity of functions and implications for CNS diseases. PflüGers Archiv : European Journal of Physiology. 465: 133-51. PMID 22535332 DOI: 10.1007/s00424-012-1102-2  0.68
2012 Wright JW, Wilson WL, Wakeling V, Boydstun AS, Jensen A, Kawas L, Harding JW. The Hepatocyte Growth Factor/c-Met Antagonist, Divalinal-Angiotensin IV, Blocks the Acquisition of Methamphetamine Dependent Conditioned Place Preference in Rats. Brain Sciences. 2: 298-318. PMID 24961196 DOI: 10.3390/brainsci2030298  0.4
2012 Wright JW, Harding JW. Importance of the brain Angiotensin system in Parkinson's disease. Parkinson's Disease. 2012: 860923. PMID 23213621 DOI: 10.1155/2012/860923  0.68
2012 Wright JW, Mizutani S, Harding JW. Focus on Brain Angiotensin III and Aminopeptidase A in the Control of Hypertension. International Journal of Hypertension. 2012: 124758. PMID 22792446 DOI: 10.1155/2012/124758  0.68
2012 Kawas LH, McCoy AT, Yamamoto BJ, Wright JW, Harding JW. Development of angiotensin IV analogs as hepatocyte growth factor/Met modifiers. The Journal of Pharmacology and Experimental Therapeutics. 340: 539-48. PMID 22129598 DOI: 10.1124/jpet.111.188136  0.68
2011 Kawas LH, Yamamoto BJ, Wright JW, Harding JW. Mimics of the dimerization domain of hepatocyte growth factor exhibit anti-Met and anticancer activity. The Journal of Pharmacology and Experimental Therapeutics. 339: 509-18. PMID 21859930 DOI: 10.1124/jpet.111.185694  0.68
2011 Wright JW, Harding JW. Brain renin-angiotensin--a new look at an old system. Progress in Neurobiology. 95: 49-67. PMID 21777652 DOI: 10.1016/j.pneurobio.2011.07.001  0.68
2011 Benoist CC, Wright JW, Zhu M, Appleyard SM, Wayman GA, Harding JW. Facilitation of hippocampal synaptogenesis and spatial memory by C-terminal truncated Nle1-angiotensin IV analogs. The Journal of Pharmacology and Experimental Therapeutics. 339: 35-44. PMID 21719467 DOI: 10.1124/jpet.111.182220  0.68
2011 Natarajan R, Wright JW, Harding JW. Nicotine-induced conditioned place preference in adolescent rats. Pharmacology, Biochemistry, and Behavior. 99: 519-23. PMID 21600911 DOI: 10.1016/j.pbb.2011.05.004  0.68
2010 Senchenkova EY, Russell J, Almeida-Paula LD, Harding JW, Granger DN. Angiotensin II-mediated microvascular thrombosis. Hypertension. 56: 1089-95. PMID 20975035 DOI: 10.1161/HYPERTENSIONAHA.110.158220  0.68
2010 Yamamoto BJ, Elias PD, Masino JA, Hudson BD, McCoy AT, Anderson ZJ, Varnum MD, Sardinia MF, Wright JW, Harding JW. The angiotensin IV analog Nle-Tyr-Leu-psi-(CH2-NH2)3-4-His-Pro-Phe (norleual) can act as a hepatocyte growth factor/c-Met inhibitor. The Journal of Pharmacology and Experimental Therapeutics. 333: 161-73. PMID 20086056 DOI: 10.1124/jpet.109.161711  0.68
2010 Leyva-Grado VH, Churchill L, Harding J, Krueger JM. The olfactory nerve has a role in the body temperature and brain cytokine responses to influenza virus. Brain, Behavior, and Immunity. 24: 281-8. PMID 19836444 DOI: 10.1016/j.bbi.2009.10.007  0.68
2010 Wright JW, Harding JW. The brain RAS and Alzheimer's disease. Experimental Neurology. 223: 326-33. PMID 19782074 DOI: 10.1016/j.expneurol.2009.09.012  0.68
2009 Wright JW, Harding JW. Contributions of matrix metalloproteinases to neural plasticity, habituation, associative learning and drug addiction. Neural Plasticity. 2009: 579382. PMID 20169175 DOI: 10.1155/2009/579382  0.68
2009 Wright JW, Meighan PC, Brown TE, Wiediger RV, Sorg BA, Harding JW. Habituation-induced neural plasticity in the hippocampus and prefrontal cortex mediated by MMP-3. Behavioural Brain Research. 203: 27-34. PMID 19389428 DOI: 10.1016/j.bbr.2009.04.014  0.68
2009 Wilson WL, Munn C, Ross RC, Harding JW, Wright JW. The role of the AT4 and cholinergic systems in the Nucleus Basalis Magnocellularis (NBM): effects on spatial memory. Brain Research. 1272: 25-31. PMID 19328191 DOI: 10.1016/j.brainres.2009.03.025  0.68
2009 Wright JW, Harding JW. The brain angiotensin IV/AT4 receptor system as a new target for the treatment of Alzheimer's disease Drug Development Research. 70: 472-480. DOI: 10.1002/ddr.20328  0.68
2008 Wright JW, Harding JW. The angiotensin AT4 receptor subtype as a target for the treatment of memory dysfunction associated with Alzheimer's disease. Journal of the Renin-Angiotensin-Aldosterone System : Jraas. 9: 226-37. PMID 19126664 DOI: 10.1177/1470320308099084  0.68
2008 Brown TE, Forquer MR, Harding JW, Wright JW, Sorg BA. Increase in matrix metalloproteinase-9 levels in the rat medial prefrontal cortex after cocaine reinstatement of conditioned place preference. Synapse (New York, N.Y.). 62: 886-9. PMID 18792988 DOI: 10.1002/syn.20562  0.68
2008 Holtfreter KL, Murphy ES, Harding JW, Wright JW. Effects of suprachiasmatic nucleus lesions on habituation of the head-shake response. Neuroscience Letters. 439: 203-7. PMID 18524489 DOI: 10.1016/j.neulet.2008.05.026  0.68
2008 Wright JW, Yamamoto BJ, Harding JW. Angiotensin receptor subtype mediated physiologies and behaviors: new discoveries and clinical targets. Progress in Neurobiology. 84: 157-81. PMID 18160199 DOI: 10.1016/j.pneurobio.2007.10.009  0.68
2008 Wright JW, Mizutani S, Harding JW. Pathways involved in the transition from hypertension to hypertrophy to heart failure. Treatment strategies. Heart Failure Reviews. 13: 367-75. PMID 17987382 DOI: 10.1007/s10741-007-9060-z  0.68
2008 Olson ML, Meighan PC, Brown TE, Asay AL, Benoist CC, Harding JW, Wright JW. Hippocampal MMP-3 elevation is associated with passive avoidance conditioning. Regulatory Peptides. 146: 19-25. PMID 17698214 DOI: 10.1016/j.regpep.2007.07.004  0.68
2007 Meighan PC, Meighan SE, Davis CJ, Wright JW, Harding JW. Effects of matrix metalloproteinase inhibition on short- and long-term plasticity of schaffer collateral/CA1 synapses. Journal of Neurochemistry. 102: 2085-96. PMID 17587312 DOI: 10.1111/j.1471-4159.2007.04682.x  0.68
2007 Wright JW, Brown TE, Harding JW. Inhibition of hippocampal matrix metalloproteinase-3 and -9 disrupts spatial memory. Neural Plasticity. 2007: 73813. PMID 17502908 DOI: 10.1155/2007/73813  0.68
2007 Brown TE, Forquer MR, Cocking DL, Jansen HT, Harding JW, Sorg BA. Role of matrix metalloproteinases in the acquisition and reconsolidation of cocaine-induced conditioned place preference. Learning & Memory (Cold Spring Harbor, N.Y.). 14: 214-23. PMID 17353546 DOI: 10.1101/lm.476207  0.68
2006 Wright JW, Meighan SE, Murphy ES, Holtfreter KL, Davis CJ, Olson ML, Benoist CC, Muhunthan K, Harding JW. Habituation of the head-shake response induces changes in brain matrix metalloproteinases-3 (MMP-3) and -9. Behavioural Brain Research. 174: 78-85. PMID 16916548 DOI: 10.1016/j.bbr.2006.07.006  0.68
2006 Davis CJ, Meighan PC, Taishi P, Krueger JM, Harding JW, Wright JW. REM sleep deprivation attenuates actin-binding protein cortactin: a link between sleep and hippocampal plasticity. Neuroscience Letters. 400: 191-6. PMID 16533564 DOI: 10.1016/j.neulet.2006.02.046  0.68
2006 Meighan SE, Meighan PC, Choudhury P, Davis CJ, Olson ML, Zornes PA, Wright JW, Harding JW. Effects of extracellular matrix-degrading proteases matrix metalloproteinases 3 and 9 on spatial learning and synaptic plasticity. Journal of Neurochemistry. 96: 1227-41. PMID 16464240 DOI: 10.1111/j.1471-4159.2005.03565.x  0.68
2006 Davis CJ, Kramár EA, De A, Meighan PC, Simasko SM, Wright JW, Harding JW. AT4 receptor activation increases intracellular calcium influx and induces a non-N-methyl-D-aspartate dependent form of long-term potentiation. Neuroscience. 137: 1369-79. PMID 16343778 DOI: 10.1016/j.neuroscience.2005.10.051  0.68
2005 Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW, Wright JW. Roles of brain angiotensins II and III in thirst and sodium appetite. Brain Research. 1060: 108-17. PMID 16182260 DOI: 10.1016/j.brainres.2005.08.032  0.68
2005 Murphy ES, Harding JW, Muhunthan K, Holtfreter KL, Wright JW. Role of mitogen-activated protein kinases during recovery from head-shake response habituation in rats. Brain Research. 1050: 170-9. PMID 15963956 DOI: 10.1016/j.brainres.2005.05.040  0.68
2004 Burns GA, Ann-Marie T, Jodie H, Harding JW. AT4 receptor binding in the developing rabbit. The Anatomical Record. Part a, Discoveries in Molecular, Cellular, and Evolutionary Biology. 281: 1276-85. PMID 15386277 DOI: 10.1002/ar.a.20070  0.68
2004 Wright JW, Murphy ES, Elijah IE, Holtfreter KL, Davis CJ, Olson ML, Muhunthan K, Harding JW. Influence of hippocampectomy on habituation, exploratory behavior, and spatial memory in rats. Brain Research. 1023: 1-14. PMID 15364013 DOI: 10.1016/j.brainres.2004.06.083  0.68
2004 Albiston AL, Pederson ES, Burns P, Purcell B, Wright JW, Harding JW, Mendelsohn FA, Weisinger RS, Chai SY. Attenuation of scopolamine-induced learning deficits by LVV-hemorphin-7 in rats in the passive avoidance and water maze paradigms. Behavioural Brain Research. 154: 239-43. PMID 15302130 DOI: 10.1016/j.bbr.2004.02.012  0.68
2004 Tseng AH, Harding JW, Craft RM. Pharmacokinetic factors in sex differences in Delta 9-tetrahydrocannabinol-induced behavioral effects in rats. Behavioural Brain Research. 154: 77-83. PMID 15302113 DOI: 10.1016/j.bbr.2004.01.029  0.68
2004 Wright JW, Harding JW. The brain angiotensin system and extracellular matrix molecules in neural plasticity, learning, and memory. Progress in Neurobiology. 72: 263-93. PMID 15142685 DOI: 10.1016/j.pneurobio.2004.03.003  0.68
2004 Olson ML, Olson EA, Qualls JH, Stratton JJ, Harding JW, Wright JW. Norleucine1-Angiotensin IV alleviates mecamylamine-induced spatial memory deficits. Peptides. 25: 233-41. PMID 15063004 DOI: 10.1016/j.peptides.2003.12.005  0.68
2003 Davis CJ, Harding JW, Wright JW. REM sleep deprivation-induced deficits in the latency-to-peak induction and maintenance of long-term potentiation within the CA1 region of the hippocampus. Brain Research. 973: 293-7. PMID 12738073 DOI: 10.1016/S0006-8993(03)02508-3  0.68
2003 Wright JW, Kramár EA, Myers ED, Davis CJ, Harding JW. Ethanol-induced suppression of LTP can be attenuated with an angiotensin IV analog. Regulatory Peptides. 113: 49-56. PMID 12686460 DOI: 10.1016/S0167-0115(02)00302-6  0.68
2003 Wright JW, Masino AJ, Reichert JR, Turner GD, Meighan SE, Meighan PC, Harding JW. Ethanol-induced impairment of spatial memory and brain matrix metalloproteinases. Brain Research. 963: 252-61. PMID 12560131 DOI: 10.1016/S0006-8993(02)04036-2  0.68
2003 Wright JW, Tamura-Myers E, Wilson WL, Roques BP, Llorens-Cortes C, Speth RC, Harding JW. Conversion of brain angiotensin II to angiotensin III is critical for pressor response in rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 284: R725-33. PMID 12433674 DOI: 10.1152/ajpregu.00326.2002  0.68
2002 Wright JW, Reichert JR, Davis CJ, Harding JW. Neural plasticity and the brain renin-angiotensin system. Neuroscience and Biobehavioral Reviews. 26: 529-52. PMID 12367589 DOI: 10.1016/S0149-7634(02)00019-2  0.68
2002 Wright JW, Kramár EA, Meighan SE, Harding JW. Extracellular matrix molecules, long-term potentiation, memory consolidation and the brain angiotensin system. Peptides. 23: 221-46. PMID 11814638 DOI: 10.1016/S0196-9781(01)00599-X  0.68
2001 Pederson ES, Krishnan R, Harding JW, Wright JW. A role for the angiotensin AT4 receptor subtype in overcoming scopolamine-induced spatial memory deficits Regulatory Peptides. 102: 147-156. PMID 11730987 DOI: 10.1016/S0167-0115(01)00312-3  0.68
2001 Wayner MJ, Armstrong DL, Phelix CF, Wright JW, Harding JW. Angiotensin IV enhances LTP in rat dentate gyrus in vivo. Peptides. 22: 1403-14. PMID 11514021 DOI: 10.1016/S0196-9781(01)00475-2  0.68
2001 Taishi P, Sanchez C, Wang Y, Fang J, Harding JW, Krueger JM. Conditions that affect sleep alter the expression of molecules associated with synaptic plasticity. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 281: R839-45. PMID 11506999  0.68
2001 Hamilton TA, Handa RK, Harding JW, Wright JW. A role for the angiotensin IV/AT4 system in mediating natriuresis in the rat Peptides. 22: 935-944. PMID 11390024 DOI: 10.1016/S0196-9781(01)00405-3  0.68
2001 Kramár EA, Armstrong DL, Ikeda S, Wayner MJ, Harding JW, Wright JW. The effects of angiotensin IV analogs on long-term potentiation within the CA1 region of the hippocampus in vitro. Brain Research. 897: 114-21. PMID 11282364 DOI: 10.1016/S0006-8993(01)02100-X  0.68
2000 Krebs LT, Hanesworth JM, Sardinia MF, Speth RC, Wright JW, Harding JW. A novel angiotensin analog with subnanomolar affinity for angiotensin- converting enzyme Journal of Pharmacology and Experimental Therapeutics. 293: 260-267. PMID 10734177  0.68
1999 Handa RK, Harding JW, Simasko SM. Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands. The Journal of Pharmacology and Experimental Therapeutics. 291: 1242-9. PMID 10565848  0.68
1999 Slinker BK, Wu Y, Brennan AJ, Campbell KB, Harding JW. Angiotensin IV has mixed effects on left ventricle systolic function and speeds relaxation Cardiovascular Research. 42: 660-669. PMID 10533606 DOI: 10.1016/S0008-6363(98)00344-7  0.68
1999 Krishnan R, Hanesworth JM, Wright JW, Harding JW. Structure-binding studies of the adrenal AT4 receptor: Analysis of position two- and three-modified angiotensin IV analogs Peptides. 20: 915-920. PMID 10503768 DOI: 10.1016/S0196-9781(99)00081-9  0.68
1999 Wright JW, Stubley L, Pederson ES, Kramár EA, Hanesworth JM, Harding JW. Contributions of the brain angiotensin IV-AT4 receptor subtype system to spatial learning. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 3952-61. PMID 10234025  0.68
1999 Zhang JH, Hanesworth JM, Sardinia MF, Alt JA, Wright JW, Harding JW. Structural analysis of angiotensin IV receptor (AT4) from selected bovine tissues. The Journal of Pharmacology and Experimental Therapeutics. 289: 1075-83. PMID 10215690  0.68
1999 Sayegh AI, Anderson NV, Harding JW, Cerpovicz P, DeBowes RM, Ritter RC, Baker GJ, Reeck G. Purification of two equine pepsinogens by use of high-performance liquid chromatography. American Journal of Veterinary Research. 60: 114-8. PMID 9918158  0.68
1998 Craft RM, Kruzich PJ, Boyer JS, Harding JW, Hanesworth JM. Sex differences in discriminative stimulus and diuretic effects of the kappa opioid agonist U69,593 in the rat. Pharmacology, Biochemistry, and Behavior. 61: 395-403. PMID 9802834 DOI: 10.1016/S0091-3057(98)00124-5  0.68
1998 Zhang JH, Stobb JW, Hanesworth JM, Sardinia MF, Harding JW. Characterization and purification of the bovine adrenal angiotensin IV receptor (AT4) using [125I]Benzoylphenylalanine-angiotensin IV as a specific photolabel Journal of Pharmacology and Experimental Therapeutics. 287: 416-424. PMID 9765364  0.68
1998 Kramár EA, Krishnan R, Harding JW, Wright JW. Role of nitric oxide in angiotensin IV-induced increases in cerebral blood flow. Regulatory Peptides. 74: 185-92. PMID 9712180 DOI: 10.1016/S0167-0115(98)00039-1  0.68
1998 Pederson ES, Harding JW, Wright JW. Attenuation of scopolamine-induced spatial learning impairments by an angiotensin IV analog Regulatory Peptides. 74: 97-103. PMID 9712169 DOI: 10.1016/S0167-0115(98)00028-7  0.68
1998 Coleman JK, Krebs LT, Hamilton TA, Ong B, Lawrence KA, Sardinia MF, Harding JW, Wright JW. Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats. Peptides. 19: 269-77. PMID 9493859 DOI: 10.1016/S0196-9781(97)00291-X  0.68
1998 Handa RK, Krebs LT, Harding JW, Handa SE. Angiotensin IV AT4-receptor system in the rat kidney American Journal of Physiology - Renal Physiology. 274: F290-F299. PMID 9486224  0.68
1997 Wright JW, Harding JW. Important roles for angiotensin III and IV in the brain renin- angiotensin system Brain Research Reviews. 25: 96-124. PMID 9370053 DOI: 10.1016/S0165-0173(97)00019-2  0.68
1997 Yang Q, Hanesworth JM, Harding JW, Slinker BK. The AT4 receptor agonist [Nle1]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart. Regulatory Peptides. 71: 175-83. PMID 9350976 DOI: 10.1016/S0167-0115(97)01033-1  0.68
1997 Chambers SL, Ronald R, Hanesworth JM, Kinder DH, Harding JW. Solid-phase synthesis of hydroxyethylamine angiotensin analogues Peptides. 18: 505-512. PMID 9210168 DOI: 10.1016/S0196-9781(96)00331-2  0.68
1997 Kramár EA, Harding JW, Wright JW. Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes. Regulatory Peptides. 68: 131-8. PMID 9110385 DOI: 10.1016/S0167-0115(96)02116-7  0.68
1997 Handa RK, Harding JW, Simasko SM. Characterization of the AT4 receptor in bovine kidney cells Faseb Journal. 11: A86.  0.68
1996 Wright JW, Bechtholt AJ, Chambers SL, Harding JW. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides. 17: 1365-71. PMID 8971933 DOI: 10.1016/S0196-9781(96)00226-4  0.68
1996 Batt CM, Jensen LL, Harding JW, Wright JW. Microinfusion of aminopeptidase M into the paraventricular nucleus of the hypothalamus in normotensive and hypertensive rats Brain Research Bulletin. 39: 235-240. PMID 8963689 DOI: 10.1016/0361-9230(95)02141-8  0.68
1996 Krebs LT, Kramár EA, Hanesworth JM, Sardinia MF, Ball AE, Wright JW, Harding JW. Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist. Regulatory Peptides. 67: 123-30. PMID 8958583 DOI: 10.1016/S0167-0115(96)00121-8  0.68
1996 Moeller I, Small DH, Reed G, Harding JW, Mendelsohn FA, Chai SY. Angiotensin IV inhibits neurite outgrowth in cultured embryonic chicken sympathetic neurones. Brain Research. 725: 61-6. PMID 8828586 DOI: 10.1016/S0006-8993(96)00246-6  0.68
1996 Chen SY, Harding JW, Barnes CD. Neuropathology of synthetic β-amyloid peptide analogs in vivo Brain Research. 715: 44-50. PMID 8739621 DOI: 10.1016/0006-8993(96)84503-3  0.68
1996 Wright JW, Clemens JA, Panetta JA, Smalstig EB, Weatherly LA, Kramár EA, Pederson ES, Mungall BH, Harding JW. Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats. Brain Research. 717: 1-11. PMID 8738247 DOI: 10.1016/0006-8993(95)01454-3  0.68
1996 Stubley-Weatherly L, Harding JW, Wright JW. Effects of discrete kainic acid-induced hippocampal lesions on spatial and contextual learning and memory in rats Brain Research. 716: 29-38. PMID 8738217 DOI: 10.1016/0006-8993(95)01589-2  0.68
1996 Handa RK, Harding JW, Handa SE. Inhibition of proximal tubule Na+ transport by angiotensin(S): Role of the at4 receptor Faseb Journal. 10: A396.  0.68
1995 Wright JW, Harding JW. Brain angiotensin receptor subtypes AT1, AT2, and AT4 and their functions Regulatory Peptides. 59: 269-295. PMID 8577933 DOI: 10.1016/0167-0115(95)00084-O  0.68
1995 Hall KL, Venkateswaran S, Hanesworth JM, Schelling ME, Harding JW. Characterization of a functional angiotensin IV receptor on coronary microvascular endothelial cells. Regulatory Peptides. 58: 107-15. PMID 8577922 DOI: 10.1016/0167-0115(95)00068-M  0.68
1995 Wright JW, Hamilton TA, Harding JW. Anomalous effects of losartan on aminopeptidase-induced reductions of blood pressure in SHR Brain Research Bulletin. 36: 169-174. PMID 7895095 DOI: 10.1016/0361-9230(94)00186-5  0.68
1995 Wright JW, Krebs LT, Stobb JW, Harding JW. The Angiotensin IV System: Functional Implications Frontiers in Neuroendocrinology. 16: 23-52. PMID 7768321 DOI: 10.1006/frne.1995.1002  0.68
1995 de Gasparo M, Husain A, Alexander W, Catt KJ, Chiu AT, Drew M, Goodfriend T, Harding JW, Inagami T, Timmermans PB. Proposed update of angiotensin receptor nomenclature. Hypertension. 25: 924-7. PMID 7737728  0.68
1995 Roberts KA, Krebs LT, Kramár EA, Shaffer MJ, Harding JW, Wright JW. Autoradiographic identification of brain angiotensin IV binding sites and differential c-Fos expression following intracerebroventricular injection of angiotensin II and IV in rats. Brain Research. 682: 13-21. PMID 7552303 DOI: 10.1016/0006-8993(95)00289-3  0.68
1994 Wright JW, Harding JW. Brain angiotensin receptor subtypes in the control of physiological and behavioral responses Neuroscience and Biobehavioral Reviews. 18: 21-53. PMID 8170622 DOI: 10.1016/0149-7634(94)90034-5  0.68
1994 Quirk WS, Coleman JKM, Hanesworth JM, Harding JW, Wright JW. Noise-induced elevations of plasma endothelin (ET-3) Hearing Research. 80: 119-122. PMID 7852197 DOI: 10.1016/0378-5955(94)90015-9  0.68
1994 Sardinia MF, Hanesworth JM, Krishnan F, Harding JW. AT4 receptor structure-binding relationship: N-terminal-modified angiotensin IV analogues Peptides. 15: 1399-1406. PMID 7700843 DOI: 10.1016/0196-9781(94)90115-5  0.68
1994 Harding JW, Wright JW, Swanson GN, Hanesworth JM, Krebs LT. AT4 receptors: Specificity and distribution Kidney International. 46: 1510-1512. PMID 7699992  0.68
1994 Wright JW, Stubley LA, Mungall BA, Harding JW. Role of the brain angiotensin system in the control of blood pressure and hypertension Asia Pacific Journal of Pharmacology. 9: 219-238.  0.68
1993 Kinney NE, Wright JW, Harding JW. Motion-induced aversions during and after recovery from olfactory nerve section in mice Physiology and Behavior. 53: 631-633. PMID 8511165 DOI: 10.1016/0031-9384(93)90166-D  0.68
1993 Hall KL, Hanesworth JM, Ball AE, Felgenhauer GP, Hosick HL, Harding JW. Identification and characterization of a novel angiotensin binding site in cultured vascular smooth muscle cells that is specific for the hexapeptide (3-8) fragment of angiotensin II, angiotensin IV Regulatory Peptides. 44: 225-232. PMID 8469776 DOI: 10.1016/0167-0115(93)90246-5  0.68
1993 Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Wright JW, Speth RC, Grove KL, Harding JW. Central angiotensin IV binding sites: Distribution and specificity in guinea pig brain Journal of Pharmacology and Experimental Therapeutics. 266: 1718-1726. PMID 8371170  0.68
1993 Hanesworth JM, Sardinia MF, Krebs LT, Hall KL, Harding JW. Elucidation of a specific binding site for angiotensin II(3-8), angiotensin IV, in mammalian heart membranes Journal of Pharmacology and Experimental Therapeutics. 266: 1036-1042. PMID 8355180  0.68
1993 Cook VI, Grove KL, Speth RC, McMenamin KM, Harding JW. Differences between perinatal angiotensin binding in the brains of SHR and WKY rats Regulatory Peptides. 45: 395-405. PMID 8351405 DOI: 10.1016/0167-0115(93)90366-G  0.68
1993 Sardinia MF, Hanesworth JM, Krebs LT, Harding JW. AT4 receptor binding characteristics: d-Amino acid- and glycine-substituted peptides Peptides. 14: 949-954. PMID 8284271 DOI: 10.1016/0196-9781(93)90071-N  0.68
1993 Wright JW, Miller-Wing AV, Shaffer MJ, Higginson C, Wright DE, Hanesworth JM, Harding JW. Angiotensin II(3-8) (ANG IV) hippocampal binding: potential role in the facilitation of memory. Brain Research Bulletin. 32: 497-502. PMID 8221142 DOI: 10.1016/0361-9230(93)90297-O  0.68
1993 Wright JW, Roberts KA, Stubley LA, Hanesworth JM, Harding JW. Hypothalamic angiotensin release in response to AII or glutamic acid stimulation of the SFO in rats. Brain Research Bulletin. 31: 649-54. PMID 8100178 DOI: 10.1016/0361-9230(93)90136-Y  0.68
1993 Roberts KA, Wright JW, Harding JW. GABA and bicuculline-induced blood pressure changes in spontaneously hypertensive rats. Journal of Cardiovascular Pharmacology. 21: 156-62. PMID 7678672  0.68
1992 Harding JW, Jensen LL, Hanesworth JM, Roberts KA, Page TA, Wright JW. Release of angiotensins in paraventricular nucleus of rat in response to physiological and chemical stimuli. The American Journal of Physiology. 262: F17-23. PMID 1733292  0.68
1992 Jensen LL, Harding JW, Wright JW. Role of paraventricular nucleus in control of blood pressure and drinking in rats American Journal of Physiology - Renal Fluid and Electrolyte Physiology. 262: F1068-F1075. PMID 1621811  0.68
1992 Harding JW, Cook VI, Miller-Wing AV, Hanesworth JM, Sardinia MF, Hall KL, Stobb JW, Swanson GN, Coleman JKM, Wright JW, Harding EC. Identification of an AII (3-8) [AIV] binding site in guinea pig hippocampus Brain Research. 583: 340-343. PMID 1504842  0.68
1992 Swanson GN, Hanesworth JM, Sardinia MF, Coleman JKM, Wright JW, Hall KL, Miller-Wing AV, Stobb JW, Cook VI, Harding EC, Harding JW. Discovery of a distinct binding site for angiotensin II (3-8), a putative angiotensin IV receptor Regulatory Peptides. 40: 409-419. PMID 1438983 DOI: 10.1016/0167-0115(92)90527-2  0.68
1992 Wright JW, Harding JW. Regulatory role of brain angiotensins in the control of physiological and behavioral responses Brain Research Reviews. 17: 227-262. PMID 1361394 DOI: 10.1016/0165-0173(92)90018-H  0.68
1991 Siemens IR, Swanson GN, Fluharty SJ, Harding JW. Solubilization and partial characterization of angiotensin II receptors from rat brain. Journal of Neurochemistry. 57: 690-700. PMID 2072111  0.68
1991 Banasik JL, Hosick H, Wright JW, Harding JW. Endothelin binding in brain of normotensive and spontaneously hypertensive rats Journal of Pharmacology and Experimental Therapeutics. 257: 302-306. PMID 1850469  0.68
1991 Murray CE, Harding JW, Wright JW. Hypotensive effects of sarthran in normotensive and spontaneously hypertensive rat strains Pharmacology, Biochemistry and Behavior. 39: 1029-1032. PMID 1763099 DOI: 10.1016/0091-3057(91)90071-9  0.68
1991 Cook VI, Grove KL, McMenamin KM, Carter MR, Harding JW, Speth RC. The AT2 angiotensin receptor subtype predominates in the 18 day gestation fetal rat brain Brain Research. 560: 334-336. PMID 1760741 DOI: 10.1016/0006-8993(91)91254-X  0.68
1991 Wright JW, Amir HZ, Murray CE, Roberts KA, Harding JW, Mizutani S, Ward PE. Use of aminopeptidase M as a hypotensive agent in spontaneously hypertensive rats. Brain Research Bulletin. 27: 545-51. PMID 1684525 DOI: 10.1016/0361-9230(91)90027-H  0.68
1991 Hall KL, Harding JW, Hosick HL. Isolation and characterization of clonal vascular smooth muscle cell lines from spontaneously hypertensive and normotensive rat aortas In Vitro Cellular and Developmental Biology - Animal. 27: 791-798. PMID 1660051  0.68
1990 Wright JW, Roberts KA, Cook VI, Murray CE, Sardinia MF, Harding JW. Intracerebroventricularly infused [D-Arg1]angiotensin III, is superior to [D-Asp1]angiotensin II, as a pressor agent in rats. Brain Research. 514: 5-10. PMID 2357530 DOI: 10.1016/0006-8993(90)90428-E  0.68
1990 Cook VI, Wright JW, Wright SA, Harding JW. Comparison of angiotensin metabolism by brain membranes from SHR and WKY rats Brain Research. 529: 320-323. PMID 2282500 DOI: 10.1016/0006-8993(90)90844-2  0.68
1990 Batt CM, Jensen LL, Hanesworth JM, Harding JW, Wright JW. Intracerebroventricularly applied peptidase inhibitors increase endogenous angiotensin levels Brain Research. 529: 126-130. PMID 2282487 DOI: 10.1016/0006-8993(90)90819-W  0.68
1990 Camara VM, Harding JW, Prieur DJ. Inherited lysozyme deficiency in rabbits. The absence of a primary isozyme of lysozyme as the cause of the condition Laboratory Investigation. 63: 544-550. PMID 2232706  0.68
1990 Wright JW, Mizutani S, Murray CE, Amir HZ, Harding JW. Aminopeptidase-induced elevations and reductions in blood pressure in the spontaneously hypertensive rat Journal of Hypertension. 8: 969-974. PMID 2174951  0.68
1989 Imboden H, Harding JW, Felix D. Hypothalamic angiotensinergic fibre systems terminate in the neurohypophysis Neuroscience Letters. 96: 42-46. PMID 2927711 DOI: 10.1016/0304-3940(89)90240-1  0.68
1989 Jensen LL, Harding JW, Wright JW. Increased blood pressure induced by central application of aminopeptidase inhibitors is angiotensinergic-dependent in normotensive and hypertensive rat strains Brain Research. 490: 48-55. PMID 2758329 DOI: 10.1016/0006-8993(89)90429-0  0.68
1989 Harding JW, Jensen LL, Quirk WS, Dewey AL, Wright JW. Brain angiotensin: Critical role in the ongoing regulation of body fluid homeostasis and cardiovascular function Peptides. 10: 261-264. PMID 2755868 DOI: 10.1016/0196-9781(89)90028-4  0.68
1989 Wright JW, Jensen LL, Cushing LL, Harding JW. Leucine aminopeptidase M-induced reductions in blood pressure in spontaneously hypertensive rats Hypertension. 13: 910-915. PMID 2737729  0.68
1989 Quirk WS, Dengerink HA, Harding JW, Bademian MJ, Swanson SJ, Wright JW. Autoregulation of cochlear blood flow in normotensive and spontaneously hypertensive rats following intracerebroventricularly mediated adjustment of blood pressure Hearing Research. 38: 119-123. PMID 2708153 DOI: 10.1016/0378-5955(89)90133-0  0.68
1989 Wright JW, Jensen LL, Roberts KA, Sardinia MF, Harding JW. Structure-function analyses of brain angiotensin control of pressor action in rats. The American Journal of Physiology. 257: R1551-7. PMID 2604011  0.68
1988 Quirk WS, Wright JW, Harding JW. Tachyphylaxis of dipsogenic activity to intracerebroventricular administration of angiotensins Brain Research. 452: 73-78. PMID 3401750 DOI: 10.1016/0006-8993(88)90010-8  0.68
1988 King SJ, Harding JW, Moe KE. Elevated salt appetite and brain binding of angiotensin II in mineralocorticoid-treated rats Brain Research. 448: 140-149. PMID 3390713 DOI: 10.1016/0006-8993(88)91110-9  0.68
1988 Dewey AL, Wright JW, Hanesworth JM, Harding JW. Effects of aminopeptidase inhibition on the half-lives of [125I]angiotensins in the cerebroventricles of the rat Brain Research. 448: 369-372. PMID 3378160 DOI: 10.1016/0006-8993(88)91279-6  0.68
1988 Jensen LL, Harding JW, Wright JW. Central effects of a specific angiotensin receptor antagonist, sarthran (Sar1, Thr8All) in normotensive and spontaneously hypertensive rat strains Brain Research. 448: 359-363. PMID 3378158 DOI: 10.1016/0006-8993(88)91277-2  0.68
1988 Wright JW, Quirk WS, Hanesworth JM, Harding JW. Influence of aminopeptidase inhibitors on brain angiotensin metabolism and drinking in rats Brain Research. 441: 215-220. PMID 3359232 DOI: 10.1016/0006-8993(88)91401-1  0.68
1988 Abhold RH, Hanesworth JM, Harding JW. Comparison of 125I-angiotensin III and 125I-angiotensin II binding to rat brain membranes Journal of Neurochemistry. 50: 831-838. PMID 3339357  0.68
1988 Harding JW, Sullivan MJ, Hanesworth JM, Cushing LL, Wright JW. Inability of [125I]Sar1,Ile8-angiotensin II to move between the blood and cerebrospinal fluid compartments Journal of Neurochemistry. 50: 554-557. PMID 3335860  0.68
1988 Abhold RH, Harding JW. Metabolism of angiotensin II and III by membrane-bound peptidases from rat brain Journal of Pharmacology and Experimental Therapeutics. 245: 171-177. PMID 3283320  0.68
1988 Wright JW, Roberts KA, Harding JW. Drinking to intracerebroventricularly infused angiotensin II, III, and IV in the SHR. Peptides. 9: 979-84. PMID 3244565 DOI: 10.1016/0196-9781(88)90076-9  0.68
1988 Felix D, Harding JW, Imboden H. The hypothalamic-angiotensin system: Location and functional considerations Clinical and Experimental Hypertension. 45-62. PMID 3243007 DOI: 10.3109/10641968809075963  0.68
1988 Batt CM, Klein EW, Harding JW, Wright JW. Pressor responses to amastatin, bestatin and Plummer's inhibitors are suppressed by pretreatment with the angiotensin receptor antagonist sarthran Brain Research Bulletin. 21: 731-735. PMID 3219604 DOI: 10.1016/0361-9230(88)90039-1  0.68
1988 Sullivan MJ, Harding JW, Wright JW. Differential effects of aminopeptides inhibitors on angiotensin-induced pressor responses Brain Research. 456: 249-253. PMID 3208081 DOI: 10.1016/0006-8993(88)90224-7  0.68
1988 Wright JW, Jensen LL, Cushing LL, Harding JW. Heightened blood pressure responsiveness to intracarotid infusion of angiotensins in the spontaneously hypertensive rat Pharmacology, Biochemistry and Behavior. 30: 343-346. PMID 3174764 DOI: 10.1016/0091-3057(88)90465-0  0.68
1988 Speth RC, Walters DE, Erickson JB, Harding JW. Measurement of angiotensin converting enzyme with mono 125I-351A. Proceedings of the Western Pharmacology Society. 31: 185-8. PMID 2850556  0.68
1987 Harding JW, Felix D. The effects of the aminopeptidase inhibitors amastatin and bestatin on angiotensin-evoked neuronal activity in rat brain Brain Research. 424: 299-304. PMID 3676828 DOI: 10.1016/0006-8993(87)91474-0  0.68
1987 Wright JW, Sullivan MJ, Quirk WS, Batt CM, Harding JW. Heightened blood pressure and drinking responsiveness to intracerebroventricularly applied angiotensins in the spontaneously hypertensive rat Brain Research. 420: 289-294. PMID 3676761 DOI: 10.1016/0006-8993(87)91249-2  0.68
1987 Rogulja I, Harding JW, Ritter S. Reduction of 125I-angiotensin II binding sites in rat brain following monosodium glutamate treatment Brain Research. 419: 333-335. PMID 3676737 DOI: 10.1016/0006-8993(87)90603-2  0.68
1987 Abhold RH, Sullivan MJ, Wright JW, Harding JW. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin Journal of Pharmacology and Experimental Therapeutics. 242: 957-962. PMID 3656120  0.68
1987 Quirk WS, Harding JW, Wright JW. Amastatin and bestatin-Induced dipsogenicity in the fSprague-Dawley Rat Brain Research Bulletin. 19: 145-147. PMID 3651838 DOI: 10.1016/0361-9230(87)90178-X  0.68
1987 Harding JW, Felix D, Sullivan MJ, Camara CA, Erickson JB, Regulja I, Abhold RF, Wright JW. The pivotal role at angiotensin III in the brain angiotensin system Proceedings of the Western Pharmacology Society. 30: 11-15. PMID 3628260  0.68
1987 Wright JW, Morseth SL, Fairley PC, Petersen EP, Harding JW. Angiotensin's contribution to dipsogenic additivity in several rodent species Behavioral Neuroscience. 101: 361-370. PMID 3606809 DOI: 10.1037//0735-7044.101.3.361  0.68
1987 Wright JW, Sullivan MJ, Bredl CR, Hanesworth JM, Cushing LL, Harding JW. Delayed cerebroventricular metabolism of [125I]angiotensins in the spontaneously hypertensive rat Journal of Neurochemistry. 49: 651-654. PMID 3598591 DOI: 10.1111/j.1471-4159.1987.tb02913.x  0.68
1987 Harding JW, Felix D. Angiotensin-sensitive neurons in the rat paraventricular nucleus: relative potencies of angiotensin II and angiotensin III Brain Research. 410: 130-134. PMID 3580891 DOI: 10.1016/S0006-8993(87)80033-1  0.68
1987 Harding JW, Felix D. Quantification of angiotensin iontophoresis Journal of Neuroscience Methods. 19: 209-215. PMID 3573813 DOI: 10.1016/S0165-0270(87)80004-3  0.68
1987 Imboden H, Harding JW, Hilgenfeldt U, Celio MR, Felix D. Localization of angiotensinogen in multiple cell types of rat brain Brain Research. 410: 74-77. PMID 3555708 DOI: 10.1016/S0006-8993(87)80022-7  0.68
1987 Imboden H, Harding JW, Abhold RH, Ganten D, Felix D. Improved immunohistochemical staining of angiotensin II in rat brain using affinity purified antibodies Brain Research. 426: 225-234. PMID 3319044 DOI: 10.1016/0006-8993(87)90876-6  0.68
1987 Imboden H, Harding JW, Ganten D, Felix D. Comparison of angiotensin II staining in rat brain using affinity purified and crude antisera Clinical and Experimental Hypertension. 1133-1139. PMID 2441911 DOI: 10.3109/10641968709160038  0.68
1986 Harding JW, Yoshida MS, Dilts RP, Woods TM, Wright JW. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat Journal of Neurochemistry. 46: 1292-1297. PMID 3950629  0.68
1986 Wright JW, Sullivan MJ, Quirk WS, Batt CM, Harding JW. Heightened pressor effect and dipsogenicity to intracerebroventricularly applied angiotensin II and III in spontaneously hypertensive rats Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 4: S408-411. PMID 3475426  0.68
1986 Felix D, Harding JW. Manipulation of aminopeptidase activities: differential effects on iontophoretically applied angiotensins in rat brain Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension. 4: S398-401. PMID 3475424  0.68
1986 Hwang BH, Wu JY, Wieczorek CM, Harding JW, Erickson JB, Wamsley JK. Different pharmacological anatomy in the paraventricular hypothalamic nucleus, supraoptic nucleus, and suprachiasmatic nucleus of rats: Quantitative autoradiography on angiotensin II receptor binding sites American Journal of Anatomy. 176: 243-247. PMID 3017087  0.68
1986 Harding JW, Erickson JB, Camara CC, Abhold RH, Wright JW. High-performance liquid chromatographic analysis of 'specifically bound' label after [125I]angiotensin II binding to rat brain membranes Neuroscience Letters. 65: 23-28. PMID 3010190 DOI: 10.1016/0304-3940(86)90114-X  0.68
1985 Petersen EP, Abhold RH, Camara CG, Wright JW, Harding JW. Characterization of angiotensin binding in the African green monkey. Brain Research. 341: 139-46. PMID 4041782 DOI: 10.1016/0006-8993(85)91481-7  0.4
1984 Petersen EP, Camara CG, Abhold RH, Wright JW, Harding JW. Characterization of angiotensin binding to gerbil brain membranes using [125I]angiotensin III as the radioligand. Brain Research. 321: 225-35. PMID 6498516 DOI: 10.1016/0006-8993(84)90176-8  0.4
1981 Schulz EM, Wright JW, Harding JW. Distinctions between stereotyped sniffing and licking in rats with methamphetamine and apomorphine Pharmacology, Biochemistry and Behavior. 15: 521-523. PMID 7197372 DOI: 10.1016/0091-3057(81)90289-6  0.68
1978 Harding JW, Getchell TV, Margolis FL. Denervation of the primary olfactory pathway in mice. V. Long-term effect of intranasal ZnSO4 irrigation on behavior, biochemistry and morphology. Brain Research. 140: 271-85. PMID 626892 DOI: 10.1016/0006-8993(78)90460-2  0.68
1977 Monti-Graziadei GA, Margolis FL, Harding JW, Graziadei PP. Immunocytochemistry of the olfactory marker protein. The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society. 25: 1311-6. PMID 336785  0.68
1976 Harding J, Margolis FL. Denervation in the primary olfactory pathway of mice. III. Effect on enzymes of carnosine metabolism Brain Research. 110: 351-360. PMID 938948 DOI: 10.1016/0006-8993(76)90407-8  0.68
Show low-probability matches.